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When are Gallbladder Polyps Malignant?
ABSTRACT
Furukawa, H., Kosuge, T., Shimada, K., Yamamoto, J.,
Kanai, Y., Mukai, K., Iwata, R. and Ushio, K., Small
Polypoid Lesions of the Gallbladder. Differential Diagnosis
and Surgical Indications by Helical Computed Tomogra-
phy. Arch Surg., 133, 735-739.
Objectives: To demonstrate the helical computed
tomographic (CT) features of small polypoid le-
sions of the gallbladder and to establish a clinical
strategy based on CT findings for the treatment
of such lesions.
Design Validation cohort study.
Setting Tertiary care public hospital.
Patients Thirty-one patients with polypoid le-
sions of the gallbladder (G3cm) underwent CT
followed by resection.
Main Outcome Measure: The detectability of the
lesions on both unenhanced and enhanced CT and
the configuration of the lesions on enhanced CT were
prospectively evaluated in comparison with the
histopathological findings.
Results: Unenhanced CT detected 14 (45%) of the
31 lesions, whereas enhanced CT detected all of
the lesions. The detection rates of the neoplasticHPB INTERNATIONAL HPB INTERNATIONAL 429
lesions (adenoma, adenocarcinoma, and metastatic
tumor) and cholesterol polyps were 81% (13/6) and
7% (1/15), respectively (P<.001). Among the 20 lesions
demonstrated as pedunculated, 6(30%) were neoplas-
tic, whereas 10 (91%) of the 11 lesions demonstrated
as sessile were neoplastic (P_<.001). When a lesion
was demonstrated on unenhanced CT or its shape
was sessile on enhanced CT, the case was diagnosed
as a neoplastic lesion. The sensitivity, specificity,
positive predictive value, negative predictive value,
and overall accuracy of the CT diagnosis of the
neoplastic lesions were 88% (14/16), 87% (13/15), 88%
(14/16), 87% (13/15), and 87% (27/31), respectively.
Conclusion: Computed tomography can differentiate
neoplastic and nonneoplastic small polypoid le-
sions of the gallbladder and reliably identify the
presence of neo-plastic lesions that should be
resected.
Keywords: Helical computed tomography, gallbladder car-
cinoma.
PAPER DISCUSSION
The report of Furukawa et al., is another study
attempting to differentiate benign polypoid le-
sions of the gallbladder from neoplastic lesions
or early gallbladder carcinoma by the use of
non-invasive radiological techniques in order to
establish a clinical strategy for treatment.
Thirty one consecutive patients who under-
went resection for a polypoid lesion of the gall-
bladder were included in the study. Patients
with small polyps (less than 5mm) and hyper-
echoic masses, thought to be a cholesterol polyp,
were excluded and one should realize that false
negative findings (missing a neoplastic lesion)
can not be analysed for the entire cohort of
patients with a "polypoid lesion".
The authors found that detectability of lesions
is much higher (100%) on enhanced CT (EHCT)
compared with unenhaced CT (UCT) (45%). The
lesions on EHCT were classified as peduncu-
lated 20/31 (65%) and sessile type 11/31 (35%).
Most sessile lesions were malignant and choles-
terol polyps are more frequently pedunculated.
Most neoplastic lesions 13/16 were also identi-
fied with UCT, but UCT did not detect the
malignant lesion in 3 patients (adenocarcinoma).
Therefore, in an attempt to increase the accu-
racy, they used both techniques with the fol-
lowing criteria; when a lesion was found on
UCT or its shape was sessile on EHCT, it was
considered as a neoplastic lesion. This strategy
increased the overall diagnostic accuracy to
87%.
In past years the size of a polypoid lesion
(more than 10mm) was considered an important
criterium to remove the gallbladder [1]. In the
present study none of the lesions less than 10
mm was malignant and using this old strategy
none of the malignant lesions would not have
been operated. Cholecystectomy was also per-
formed, however, in 10 patients with cholesterol
polyps and two patients with adenoma. The
introduction of this new above mentioned
strategy might prevent these unnecessary cho-
lecystectomies, however neoplastic lesions with
curative options will be missed in 13%.
Shindoh recently suggested that unenhaced
CT scan examination is effective for differentia-
tion of benign and malignant lesions [2]. In the
present study, however, only 81% of neoplastic
lesions were found by UCT. Using these criteria
(only UCT) there is doubt if the risk of missing
a malignant lesion is acceptable.
It is not clear from both studies whether all
patients who had neoplastic lesions not detect-
ed at UCT, did not have symptoms. This should
be another argument to perform a cholecystec-
tomy in these patients and probably detect the
otherwise missed lesions and further decrease
the chance of missing a malignancy. It has been
shown previously that symptomatic patients
with solitary polypoid lesions had a higher risk
for developing gallbladder carcinoma [3].
Studies on the natural history of polypoid
lesions are limited. Moriguchi reported in an
observational study of 5 years in 109 patients
that the size of the lesion did not change in
88% and that there was no correlation between
the initial size (<_ 5mm; 6-9mm; >_ 10mm) and
the percentage, with a change in diameter dur-430 HPB INTERNATIONAL
ing follow-up nor a correlation with age and
patient’s sex [4]. The authors concluded that
most poylpoid lesions are benign.
Other are not in agreement and suggest an
underestimation of the risk for malignancy,
probably because of the patient selection (only 2
single lesions _>10mm) and a more aggressive
approach is recommended [5,6]. Another argu-
ment for an aggressive approach is the relatively
simple initial surgical treatment with minimal
morbidity and mortality and on the other hand
the dismal prognosis of gallbladder carcinoma
[1,71.
It has been suggested that small lesion in
patients without symptoms should not be
removed, except for those patients with enlarg-
ing lesions or thickening of the gallbladder
wall during follow-up by ultrasonography or
CT. In the present study the number of small
lesions was limited, but all proved to be be-
nign. Recently, however, Shinkai et al., has re-
ported that most cholesterol polyps (97%) are
less than 10mm, but the mean diameter of ade-
noma was 6+3.4mm. Six percent of neoplasms
were observed among polyps less than 5mm.
Shinkai suggested an aggressive approach re-
gardless of size, in particular for single lesions [3].
One should also realize, although the risk is low,
that adenomyomatosis has a malignant poten-
tial and in a few patients even carcinoma associ-
ated with cholesterolosis has been described
[1,8,9].
Most studies have relatively small patient
numbers. In addition the selection bias of
patients, the lack of sufficient follow-up in
nearly all studies with a non surgical treatment
strategy and the different findings between
studies, preclude a proposal for an evidence
based treatment strategy for polypoid lesions
of the gallbladder.
Regarding the above mentioned risks, in
particular single polyps in symptomatic older
patients, polyps larger than 10mm or polyps
with an increase in size should be removed. This
should also be performed for other polypoid
lesions, if patients are not willing to undergo
long term careful follow-up.
The use of enhanced CT, however, could pre-
vent unnecessary cholecystectomy in a number
of patients, but radiological evaluation during
follow-up is indicated.
Another issue not addressed in this discussion
is the appropriate approach how to remove the
gallbladder, laparoscopically or with an open
procedure. For small low risk lesions a laparo-
scopic approach could be accepted. CT might
also be helpful to identify high risk patients for a
milignancy. An open approach should be pre-
ferred in these patients to prevent port site
metastasis.
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